Denka Markova

2.7k citations
19 papers · 1.8k · 1 hit paper · h-index 8

Impact in

  • Oncology top 2%
    • PARP inhibition in cancer therapy
    • HER2/EGFR in Cancer Research
    • Cancer Immunotherapy and Biomarkers
    • Cancer Genomics and Diagnostics
    • Breast Cancer Treatment Studies

Papers in

    • Thyroid and Parathyroid Surgery 6
    • PARP inhibition in cancer therapy 4

Denka Markova

18 papers receiving 1.7k citations

Denka Markova's Hit Papers

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation 2018 · 1.4k citations
1.4k0+2+5Years since publication4008001.2k

Peers

Denka Markova
Comparison fields: 5 of 84
  • Oncology 1.1k
  • Cancer Research 318
  • Genetics 388
  • Pulmonary and Respiratory Medicine 403
  • Molecular Biology 520
Replace Maria A. Caligo with:
Maria A. Caligo Italy
Sabine Zumstein-Mecker Switzerland
Meritxell Bellet Spain
Lars Ottestad Norway
Peggy Manders Netherlands
Janice Lu United States
Maria Martinez‐García Spain
Renata A. Coudry Brazil
Sofía Braga Portugal
Sonali Jindal United States
Denka Markova relative to Maria A. Caligo Italy Maria A. Caligo's profile →
Citations per field
00.5×7.3×
Maria A. Caligo · 1×
Citations per year

Countries citing papers authored by Denka Markova

Since Specialization
Citations

This map shows the geographic impact of Denka Markova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denka Markova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denka Markova more than expected).

Fields of papers citing papers by Denka Markova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denka Markova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denka Markova. The network helps show where Denka Markova may publish in the future.

Co-authors

The 25 scholars most cited alongside Denka Markova, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Denka Markova Line = papers co-authored together Denka Markova links everyone, so they are left out of the graph.

All Works

19 of 19 papers shown
#Work
1
Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
Hit paper breakdown →
20181450
2 2018109
3 201551
4 201036
5 202034
6 202132
7 202111
8 20189
9 20167
10
Pleural effusions in acute pancreatitis.
20004
11 20184
12 20203
13
[Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
20093
14 20222
15 20182
16
[Role of total inhibin in diagnosis and monitoring of ovarian cancer in postmenopausal women].
20081
17
[Ovarian cancer with metastatic lesion in the vagina (foetus papiraceus)].
20091
18 20221
19 20260

About Denka Markova

Denka Markova is a scholar working on Surgery, Oncology, Genetics, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 19 papers that have together received 1.8k indexed citations. Recurring topics across this work include Thyroid and Parathyroid Surgery (6 papers), PARP inhibition in cancer therapy (4 papers), BRCA gene mutations in cancer (3 papers), Advanced Breast Cancer Therapies (2 papers), Estrogen and related hormone effects (1 paper), DNA Repair Mechanisms (1 paper), Genetic Syndromes and Imprinting (1 paper) and Neuroendocrine Tumor Research Advances (1 paper). The work is most often cited by research in Oncology (1.1k citations), Cancer Research (318 citations), Genetics (388 citations), Pulmonary and Respiratory Medicine (403 citations) and Molecular Biology (520 citations). Denka Markova has collaborated with scholars based in United States, Germany and Spain. Frequent co-authors include Hope S. Rugo, Anthony Gonçalvès, W. Eiermann, Rinat Yerushalmi, Jennifer K. Litton, Johannes Ettl, Sara A. Hurvitz, Ruben G.W. Quek, Alison L. Hannah and Lida A. Mina. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Clinical Nursing Research, The Journal of Clinical Endocrinology & Metabolism and Journal of Bone and Mineral Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact